Tremfya Leads TV Pharma Ads in September and Q3
College football and Spanish language TV delivered the majority of TV pharma ad impressions in September.
Johnson & Johnson's Tremfya retained the top spot for TV pharma brand ad impressions in September, with an impressions share of voice (SOV) of 5.02% and 3.1 billion impressions, following a $32.8 million ad spend.
- Tremfya's ad spend increased by approximately $10 million compared to August.
- The psoriasis/ulcerative colitis drug scored most of its impressions from Univision's ¡Despierta América!
Vicks took the runner-up title, knocking AbbVie's Skyrizi to third place, with an impressions SOV of 4.71% and 2.9 billion impressions, primarily through CBS and its show GMA 3: What You Need to Know, after investing $10.3 million in TV ad spend.
The fall sports season got underway in earnest.
Author's summary: Tremfya leads TV pharma ads.